Showing results (201-210 of 215) with videos related to
Sort By:
Pageof 22
Antimicrobial Agents and Chemotherapy|December 28, 2007
The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviralEdward P Garvey, Brian A Johns, Margaret J Gartland, et al.Frontiers in Immunology|November 27, 2018
IgG Induced by Vaccination With Ascaris suum Extracts Is Protective Against InfectionAna Clara Gazzinelli-Guimarães, Pedro Henrique Gazzinelli-Guimarães, Denise Silva Nogueira, et al.The British Journal of Ophthalmology|January 14, 2026
Orbital inflammation in VEXAS syndromeClare Quigley, James Pietris, Terence Ang, et al.Eclinicalmedicine|April 20, 2026
Effect of different management strategies on outcomes in subarachnoid neurocysticercosis: a descriptive, multicentre, retrospective cohort study in the USAJanitzio J Guzmán, Megan M Duffey, Jill Weatherhead, et al.Journal of Medicinal Chemistry|May 16, 2013
Discovery of a potent boronic acid derived inhibitor of the HCV RNA-dependent RNA polymeraseAndrew Maynard, Renae M Crosby, Byron Ellis, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 28, 2015
The Emergence of Zoonotic Onchocerca lupi Infection in the United States--A Case-SeriesPaul T Cantey, Jessica Weeks, Morven Edwards, et al.The British Journal of Dermatology|May 4, 2019
Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) studyK Molloy, C Jonak, F J S H Woei-A-Jin, et al.Journal of Fish Biology|March 15, 2018
Fishes in a changing world: learning from the past to promote sustainability of fish populationsT A C Gordon, H R Harding, F K Clever, et al.Nature|April 11, 2009
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancerTeresa A Soucy, Peter G Smith, Michael A Milhollen, et al.Journal of Medicinal Chemistry|November 11, 2011
Discovery of a potent and orally bioavailable benzolactam-derived inhibitor of Polo-like kinase 1 (MLN0905)Matthew O Duffey, Tricia J Vos, Ruth Adams, et al.Pageof 22